IP Library Granted Patent US 9,115,386
Granted Patent B2
US 9,115,386 · App. 13/120,861 · Granted Aug 25, 2015

Selective oxidation of 5-methylcytosine by TET-family proteins

Inventors: Anjana Rao (Cambridge, MA); Mamta Tahiliani (New York, NY); Kian Peng Koh (Jamaica Plain, MA); Suneet Agarwal (Belmont, MA); Aravind Iyer (Bethesda, MD)
Assignee: CHILDREN'S MEDICAL CENTER CORPORATION
C12Q1/6806C12N5/0018C12N9/0071C12Q1/26C12Q1/6827G01N33/5011G01N33/5308G01N2500/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,115,386
App. No.
13/120,861
Granted
Aug 25, 2015
Kind
B2
Abstract

The present invention provides for novel methods for regulating and detecting the cytosine methylation status of DNA. The invention is based upon identification of a novel and surprising catalytic activity for the family of TET proteins, namely TET1, TET2, TET3, and CXXC4. The novel activity is related to the enzymes being capable of converting the cytosine nucleotide 5-methylcytosine into 5-hydroxymethylcytosine by hydroxylation.

Claims (2)

1. A kit for detecting a naturally occurring 5-hydroxymethylcytosine nucleotide in a biological sample comprising DNA of mammalian cells, the kit comprising: (1) an antibody or a binding portion thereof that binds to the naturally occurring 5-hydroxymethylcytosine nucleotide, (2) a catalytically active TET family enzyme, a functional TET family derivative, a TET family catalytically active fragment thereof, or combination thereof; and (3) packaging materials and instructions to extract a DNA sample from the biological sample.

2. The method of claim 1 , wherein the antibody or a binding portion thereof that binds to the naturally occurring 5-hydroxymethylcytosine nucleotide is labeled.

Assignments (4)
CONFIRMATORY LICENSE Recorded Mar 2, 2022
From: BOSTON CHILDREN'S HOSPITAL
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 059693/0334 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2016
From: IYER, ARAVIND
To: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 039550/0560 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 18, 2014
From: THE CHILDREN'S HOSPITAL CORPORATION
To: CHILDREN'S MEDICAL CENTER CORPORATION
Reel/Frame 034197/0510 →
MERGER Recorded Aug 28, 2014
From: IMMUNE DISEASE INSTITUTE, INC.
To: THE CHILDREN'S HOSPITAL CORPORATION
Reel/Frame 033631/0543 →
Continuity (4)
Provisional Application 61100503 · Sep 26, 2008
Provisional Application 61100995 · Sep 29, 2008
Provisional Application 61121844 · Dec 11, 2008
Related Publication 20110236894A1 · Sep 29, 2011